Clinical Trial Update: A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of RBD4059 in Participants With Stable Coronary Artery Disease [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical study evaluating the safety, pharmacokinetics, and pharmacodynamics of RBD4059 in participants with stable coronary artery disease. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Coronary Artery Disease

Drugs mentioned

• RBD4059

Snippet

Sponsor: Ribocure Pharmaceuticals AB | Conditions: Stable Coronary Artery Disease CAD | Phase 2 | Status: ACTIVE_NOT_RECRUITING